EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduced Cocaine Craving and Self-Reported Abstinence During Tirzepatide Treatment in Two Patients with Obesity: A Case Series

Luigi Giuseppe de Filippis, Antonio Bruno

International Journal of Environmental Research and Public Health · 14.11.2026 · 23 (11) · 1415

DOI: 10.3390/ijerph23111415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Environmental Research and Public Health, online erschienen am 14.11.2026. Verfasst von Luigi Giuseppe de Filippis und 1 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cocaine use disorder (CUD) remains a major clinical challenge for which no pharmacological treatment has established efficacy. Experimental evidence suggests that incretin signalling may influence neural reward pathways involved in substance use, and preliminary clinical observations with glucagon-like peptide-1 (GLP-1) receptor agonists have suggested a possible reduction in cocaine craving. We describe a 40-year-old man and a 39-year-old woman with long-standing, approximately weekly intranasal cocaine use (for 9 and 8 years, respectively) who received tirzepatide for obesity, starting at 2.5 mg once weekly and titrated through 5 mg and 7.5 mg to 10 mg weekly. Within the first month, both patients spontaneously reported reduced cocaine craving and decreased frequency of use. Both reported complete cessation in February 2026 and continued to report abstinence during monthly clinical follow-up. A single urine drug screen performed in July 2026 was negative for cocaine in both patients; this point-in-time result does not establish continuous abstinence. At 3 months, body weight had decreased by 11 kg and 9 kg, respectively. No adverse effects were spontaneously reported. These cases describe a temporal association between tirzepatide treatment, reported reductions in cocaine craving and use, and subsequent self-reported abstinence. Causality cannot be inferred, and the observations are hypothesis-generating.

Zitieren

APA

Filippis, L. G. D., & Bruno, A. (2026). Reduced Cocaine Craving and Self-Reported Abstinence During Tirzepatide Treatment in Two Patients with Obesity: A Case Series. International Journal of Environmental Research and Public Health, 23(11), 1415. https://doi.org/10.3390/ijerph23111415

Vancouver

Filippis LGD, Bruno A. Reduced Cocaine Craving and Self-Reported Abstinence During Tirzepatide Treatment in Two Patients with Obesity: A Case Series. International Journal of Environmental Research and Public Health. 2026;23(11):1415. doi:10.3390/ijerph23111415

BibTeX
@article{Filippis2026,
  author = {Filippis, Luigi Giuseppe de and Bruno, Antonio},
  title = {Reduced Cocaine Craving and Self-Reported Abstinence During Tirzepatide Treatment in Two Patients with Obesity: A Case Series},
  journal = {International Journal of Environmental Research and Public Health},
  year = {2026},
  volume = {23},
  number = {11},
  pages = {1415},
  doi = {10.3390/ijerph23111415}
}
Kostenlos starten →